2016 → 2026​: Genomics has had its glow-up

6th February, 2026 Dr Natalie Thorne

2016 → 2026​: Genomics has had its glow-up.​

In 2016:​
💸 Sequencing was very expensive​
📅 Turnaround time was measured in months​
🤷🏻‍♀️ Genomics was still “specialist”​

And Genomical was just an idea on paper 📝​

In 2026:​
⏰ Sequencing is routine​
🩺 Clinical genomics is mainstream​
🏥 Genomics is shaping diagnosis, treatment, and prevention​

But here’s the part that looks more like 2016 than 2026: the infrastructure underneath it all.​

Data workflows are still stitched together with ad hoc processes. Storage, reporting, and governance are bolted onto pipelines that were never designed for national-scale healthcare, evolving cyber risk, or the long-term value of genomic data.​

The science moved fast.​
The systems didn’t.​

And that gap is now one of the biggest constraints on access, scale, and sustainability in clinical genomics.​

If any of this resonates, we should be talking. Send us a message now to learn how Genomical (no longer just an idea on paper) can help you.​

About the author

Dr Natalie Thorne Chief Scientific Officer

Read Full Bio
  2016 → 2026​: Genomics has had its glow-up Back to top